76 related articles for article (PubMed ID: 9070662)
1. MDM-2 protein is expressed in different layers of normal human skin.
Dazard JE; Augias D; Neel H; Mils V; Marechal V; Basset-Séguin N; Piette J
Oncogene; 1997 Mar; 14(9):1123-8. PubMed ID: 9070662
[TBL] [Abstract][Full Text] [Related]
2. MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: association with wild-type p53 accumulation.
Pruneri G; Pignataro L; Carboni N; Luminari S; Capaccio P; Neri A; Buffa R
Mod Pathol; 1997 Aug; 10(8):785-92. PubMed ID: 9267820
[TBL] [Abstract][Full Text] [Related]
3. MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.
Ganguli G; Abecassis J; Wasylyk B
EMBO J; 2000 Oct; 19(19):5135-47. PubMed ID: 11013216
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
Jang TJ
Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
[TBL] [Abstract][Full Text] [Related]
5. Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size.
Dazard JE; Piette J; Basset-Seguin N; Blanchard JM; Gandarillas A
Oncogene; 2000 Aug; 19(33):3693-705. PubMed ID: 10949923
[TBL] [Abstract][Full Text] [Related]
6. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
Hughes JH; Robinson RA
Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and molecular evaluation of the mdm-2 gene product in bronchogenic carcinoma.
Gorgoulis VG; Rassidakis GZ; Karameris AM; Papastamatiou H; Trigidou R; Veslemes M; Rassidakis AN; Kittas C
Mod Pathol; 1996 May; 9(5):544-54. PubMed ID: 8733770
[TBL] [Abstract][Full Text] [Related]
9. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
10. Mdm-2 is not induced by p53 in human keratinocytes in vivo.
Burden AD; Stables GI; Campbell I; Thomson W; MacKie RM
J Cutan Pathol; 1996 Feb; 23(1):25-9. PubMed ID: 8720983
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
12. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
Mayo LD; Berberich SJ
Oncogene; 1996 Dec; 13(11):2315-21. PubMed ID: 8957072
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-6 protein in normal skin and epidermal neoplasms.
Kanazawa N; Moriyama M; Onizuka T; Sugawara K; Mori S
Pathol Int; 1997 Sep; 47(9):600-7. PubMed ID: 9311010
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of MDM-2 in breast carcinomas.
Bueso-Ramos CE; Manshouri T; Haidar MA; Yang Y; McCown P; Ordonez N; Glassman A; Sneige N; Albitar M
Breast Cancer Res Treat; 1996; 37(2):179-88. PubMed ID: 8750585
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes.
Olson DC; Marechal V; Momand J; Chen J; Romocki C; Levine AJ
Oncogene; 1993 Sep; 8(9):2353-60. PubMed ID: 7689721
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-fos proto-oncogene mRNA in non-melanoma skin cancer.
Takahashi S; Pearse AD; Marks R
J Dermatol Sci; 1994 Feb; 7(1):54-62. PubMed ID: 8193084
[TBL] [Abstract][Full Text] [Related]
17. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
20. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
